Saved in:
Bibliographic Details
Main Author: Tomas Gabriel Bas
Format: Artículo científico
Language:en
Published: Universidad Alberto Hurtado 2006
Subjects:
Online Access:https://www.redalyc.org/articulo.oa?id=84710202
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866568640462061568
author Tomas Gabriel Bas
author_facet Tomas Gabriel Bas
contents Cooperation agreements in biotechnology companies: an advantage for the acquisition of new capabilities and growth? Tomas Gabriel Bas Ingeniería Cooperation agreements in biotechnology allow us to observe the complexity surrounding alliances. The market globalization, the exorbitant costs of R&D and the rapid changes in technology, are arguably amongst the principal reasons that push companies to establish cooperation agreements. Biotechnology companies use this instrument to develop external features in the search for resources and missing expertise. This paper sets out to identify if such cooperation agreements in biotechnology companies are an advantage in themselves, sufficient for the acquisition of new capabilities and if they help the growth of these companies. For this approach, a private database of companies in the two most advanced countries in this sector: United States and United Kingdom, will be used. 2006 artículo científico 0718-2724 https://www.redalyc.org/articulo.oa?id=84710202 en http://www.redalyc.org/revista.oa?id=847 Journal of Technology Management & Innovation application/pdf Universidad Alberto Hurtado Journal of Technology Management & Innovation (Chile) Num.2 Vol.1
format Artículo científico
id redalyc_84710202
language en
publishDate 2006
publisher Universidad Alberto Hurtado
spellingShingle Cooperation agreements in biotechnology companies: an advantage for the acquisition of new capabilities and growth?
Tomas Gabriel Bas
Ingeniería
Cooperation agreements in biotechnology companies: an advantage for the acquisition of new capabilities and growth? Tomas Gabriel Bas Ingeniería Cooperation agreements in biotechnology allow us to observe the complexity surrounding alliances. The market globalization, the exorbitant costs of R&D and the rapid changes in technology, are arguably amongst the principal reasons that push companies to establish cooperation agreements. Biotechnology companies use this instrument to develop external features in the search for resources and missing expertise. This paper sets out to identify if such cooperation agreements in biotechnology companies are an advantage in themselves, sufficient for the acquisition of new capabilities and if they help the growth of these companies. For this approach, a private database of companies in the two most advanced countries in this sector: United States and United Kingdom, will be used. 2006 artículo científico 0718-2724 https://www.redalyc.org/articulo.oa?id=84710202 en http://www.redalyc.org/revista.oa?id=847 Journal of Technology Management & Innovation application/pdf Universidad Alberto Hurtado Journal of Technology Management & Innovation (Chile) Num.2 Vol.1
title Cooperation agreements in biotechnology companies: an advantage for the acquisition of new capabilities and growth?
topic Ingeniería
url https://www.redalyc.org/articulo.oa?id=84710202